165 related articles for article (PubMed ID: 24396608)
1. Epidemiology and prognosis of paraneoplastic syndromes in hepatocellular carcinoma.
Chang PE; Ong WC; Lui HF; Tan CK
ISRN Oncol; 2013; 2013():684026. PubMed ID: 24396608
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study.
Burciu C; Sirli R; Bende R; Vuletici D; Miutescu B; Moga T; Bende F; Popescu A; Sporea I; Koppandi O; Miutescu E; Iovanescu D; Danila M
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674198
[No Abstract] [Full Text] [Related]
3. Paraneoplastic syndrome frequency and prognostic effect in hepatocellular carcinoma patients.
Ülger Y; Delik A
Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):769-773. PubMed ID: 34974464
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic syndromes in hepatocellular carcinoma: a review.
Ong Y; Huey CWT; Shelat VG
Expert Rev Gastroenterol Hepatol; 2022 May; 16(5):449-471. PubMed ID: 35649187
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
Luo JC; Hwang SJ; Wu JC; Lai CR; Li CP; Chang FY; Chiang JH; Lui WY; Chu CW; Lee SD
Hepatogastroenterology; 2002; 49(47):1315-9. PubMed ID: 12239934
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role and significance of paraneoplastic syndromes in hepatocellular carcinoma.
Qu Q; Wang S; Chen S; Zhou L; Rui JA
Am Surg; 2014 Feb; 80(2):191-6. PubMed ID: 24480222
[TBL] [Abstract][Full Text] [Related]
7. [The incidence and clinical significance of paraneoplastic syndromes in patients with hepatocellular carcinoma].
Huh UY; Kim JH; Kim BH; Nam KD; Jang JY; Kim NH; Lee SK; Joo KR; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
Korean J Hepatol; 2005 Sep; 11(3):275-83. PubMed ID: 16177554
[TBL] [Abstract][Full Text] [Related]
8. Manifestations of hypercholesterolaemia, hypoglycaemia, erythrocytosis and hypercalcaemia in patients with hepatocellular carcinoma: report of two cases.
Chu CW; Hwang SJ; Luo JC; Tsay SH; Li CP; Chang FY; Lee SD; Lui WY; Chiang JH
J Gastroenterol Hepatol; 1999 Aug; 14(8):807-10. PubMed ID: 10482434
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy.
Moreira DM; Gershman B; Lohse CM; Boorjian SA; Cheville JC; Leibovich BC; Thompson RH
World J Urol; 2016 Oct; 34(10):1465-72. PubMed ID: 26914818
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of erythrocytosis in patients with hepatocellular carcinoma.
Hwang SJ; Lee SD; Wu JC; Chang CF; Lu CL; Tsay SH; Lo KJ
Zhonghua Yi Xue Za Zhi (Taipei); 1994 May; 53(5):262-9. PubMed ID: 7518732
[TBL] [Abstract][Full Text] [Related]
11. The incidence and characteristics of some paraneoplastic syndromes of hepatocellular carcinoma in Nigerian patients.
Ndububa DA; Ojo OS; Adetiloye VA; Rotimi O; Durosinmi MA; Uchegbu LO
Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1401-4. PubMed ID: 10654801
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytosis as a Rare Paraneoplastic Syndrome Occurring in Hepatocellular Carcinoma: A Case Report.
Abbas H; Hanif S; Tariq H; Chilimuri S
Gastroenterology Res; 2019 Apr; 12(2):96-99. PubMed ID: 31019620
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan.
Luo JC; Hwang SJ; Wu JC; Li CP; Hsiao LT; Lai CR; Chiang JH; Lui WY; Chang FY; Lee SD
Cancer; 1999 Sep; 86(5):799-804. PubMed ID: 10463978
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular Carcinoma Without Cirrhosis Presenting With Hypercalcemia: Case Report and Literature Review.
Newman NB; Jabbour SK; Hon JD; Berman JJ; Malik D; Carpizo D; Moss RA
J Clin Exp Hepatol; 2015 Jun; 5(2):163-6. PubMed ID: 26155045
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic syndromes in primary liver cell carcinoma in Nigeria.
Teniola SO; Ogunleye IO
Trop Geogr Med; 1994; 46(1):20-2. PubMed ID: 8165731
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system.
Sun R; Breau RH; Mallick R; Tanguay S; Pouliot F; Kapoor A; Lavallée LT; Finelli A; So AI; Rendon RA; Fairey AS; Lattouf JB; Kawakami J; Bhindi B; Basappa NS; Wood LA; Bjarnason GA; Heng DYC; Bansal RK
Can Urol Assoc J; 2021 Apr; 15(4):132-137. PubMed ID: 33007184
[TBL] [Abstract][Full Text] [Related]
17. Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma.
Hegemann M; Kroeger N; Stenzl A; Bedke J
World J Urol; 2018 Jun; 36(6):849-854. PubMed ID: 29429069
[TBL] [Abstract][Full Text] [Related]
18. Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome.
Chang PE; Ong WC; Lui HF; Tan CK
J Gastroenterol; 2008; 43(11):881-8. PubMed ID: 19012042
[TBL] [Abstract][Full Text] [Related]
19. Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.
Hwang SJ; Luo JC; Li CP; Chu CW; Wu JC; Lai CR; Chiang JH; Chau GY; Lui WY; Lee CC; Chang FY; Lee SD
World J Gastroenterol; 2004 Sep; 10(17):2472-7. PubMed ID: 15300887
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological study of juvenile hepatocellular carcinoma].
Furusawa A; Unoura M; Notsumata K; Morioka T; Hayakawa K; Matsushita E; Kobayashi K; Hattori N; Makino H; Fukuoka K
Nihon Shokakibyo Gakkai Zasshi; 1989 Dec; 86(12):2765-72. PubMed ID: 2483177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]